169 related articles for article (PubMed ID: 25202384)
1. Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells.
Liu J; Shu Y; Zhang Q; Liu B; Xia J; Qiu M; Miao H; Li M; Zhu R
Oncol Lett; 2014 Oct; 8(4):1645-1651. PubMed ID: 25202384
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells.
Jiang L; Ye WC; Li Z; Yang Y; Dai W; Li M
BMC Complement Med Ther; 2021 Jul; 21(1):194. PubMed ID: 34229692
[TBL] [Abstract][Full Text] [Related]
3. Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells.
Huang X; Lian T; Guan X; Liu B; Hao S; Zhang J; Bao S; Tan X; Zhu R
Protein Pept Lett; 2017; 24(5):419-424. PubMed ID: 28240161
[TBL] [Abstract][Full Text] [Related]
4. Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer.
Wu J; Xiao Z; Li H; Zhu N; Gu J; Wang W; Liu C; Wang W; Qin L
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884547
[TBL] [Abstract][Full Text] [Related]
5. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
[TBL] [Abstract][Full Text] [Related]
6. Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells.
Lu CJ; He YF; Yuan WZ; Xiang LJ; Zhang J; Liang YR; Duan J; He YH; Li MY
World J Gastroenterol; 2017 Sep; 23(34):6242-6251. PubMed ID: 28974890
[TBL] [Abstract][Full Text] [Related]
7. Dihydromyricetin Inhibits Lead-Induced Cognitive Impairments and Inflammation by the Adenosine 5'-Monophosphate-Activated Protein Kinase Pathway in Mice.
Liu CM; Yang W; Ma JQ; Yang HX; Feng ZJ; Sun JM; Cheng C; Jiang H
J Agric Food Chem; 2018 Aug; 66(30):7975-7982. PubMed ID: 29975840
[TBL] [Abstract][Full Text] [Related]
8. Anti-HSV-1 effect of dihydromyricetin from Ampelopsis grossedentata via the TLR9-dependent anti-inflammatory pathway.
Zhou HY; Gao SQ; Gong YS; Lin T; Tong S; Xiong W; Shi CY; Wang WQ; Fang JG
J Glob Antimicrob Resist; 2020 Dec; 23():370-376. PubMed ID: 33161114
[TBL] [Abstract][Full Text] [Related]
9. Dihydromyricetin Inhibits α-Synuclein Aggregation, Disrupts Preformed Fibrils, and Protects Neuronal Cells in Culture against Amyloid-Induced Cytotoxicity.
Jia L; Wang Y; Sang J; Cui W; Zhao W; Wei W; Chen B; Lu F; Liu F
J Agric Food Chem; 2019 Apr; 67(14):3946-3955. PubMed ID: 30900456
[TBL] [Abstract][Full Text] [Related]
10. Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway.
Huang H; Hu M; Zhao R; Li P; Li M
Oncol Rep; 2013 Nov; 30(5):2467-75. PubMed ID: 24002546
[TBL] [Abstract][Full Text] [Related]
11. Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism.
Zhang Q; Liu J; Liu B; Xia J; Chen N; Chen X; Cao Y; Zhang C; Lu C; Li M; Zhu R
Sci Rep; 2014 Apr; 4():4628. PubMed ID: 24717393
[TBL] [Abstract][Full Text] [Related]
12. Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells.
Wu S; Liu B; Zhang Q; Liu J; Zhou W; Wang C; Li M; Bao S; Zhu R
PLoS One; 2013; 8(11):e76886. PubMed ID: 24223706
[TBL] [Abstract][Full Text] [Related]
13. Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells.
Zeng G; Liu J; Chen H; Liu B; Zhang Q; Li M; Zhu R
Oncol Rep; 2014 Jun; 31(6):2713-9. PubMed ID: 24789439
[TBL] [Abstract][Full Text] [Related]
14. Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.
Jiang L; Zhang Q; Ren H; Ma S; Lu C; Liu B; Liu J; Liang J; Li M; Zhu R
PLoS One; 2015; 10(4):e0124994. PubMed ID: 25915649
[TBL] [Abstract][Full Text] [Related]
15. Dihydromyricetin induces cell apoptosis via a p53-related pathway in AGS human gastric cancer cells.
Ji FJ; Tian XF; Liu XW; Fu LB; Wu YY; Fang XD; Jin HY
Genet Mol Res; 2015 Dec; 14(4):15564-71. PubMed ID: 26634523
[TBL] [Abstract][Full Text] [Related]
16. Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice.
Xie J; Liu J; Chen TM; Lan Q; Zhang QY; Liu B; Dai D; Zhang WD; Hu LP; Zhu RZ
World J Gastroenterol; 2015 May; 21(18):5473-81. PubMed ID: 25987769
[TBL] [Abstract][Full Text] [Related]
17. Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.
Zhang QY; Li R; Zeng GF; Liu B; Liu J; Shu Y; Liu ZK; Qiu ZD; Wang DJ; Miao HL; Li MY; Zhu RZ
World J Gastroenterol; 2014 Aug; 20(29):10082-93. PubMed ID: 25110435
[TBL] [Abstract][Full Text] [Related]
18. Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.
Liu B; Zhou W; Chen X; Xu F; Chen Y; Liu J; Zhang Q; Bao S; Chen N; Li M; Zhu R
Mol Med Rep; 2015 Mar; 11(3):1609-14. PubMed ID: 25376731
[TBL] [Abstract][Full Text] [Related]
19. Dihydromyricetin inhibits cell proliferation, migration, invasion and promotes apoptosis
Chen L; Yang ZS; Zhou YZ; Deng Y; Jiang P; Tan SL
J Cancer; 2020; 11(19):5689-5699. PubMed ID: 32913463
[TBL] [Abstract][Full Text] [Related]
20. Dihydromyricetin from ampelopsis grossedentata protects against vascular neointimal formation via induction of TR3.
Huang B; Li Y; Yao Y; Shu W; Chen M
Eur J Pharmacol; 2018 Nov; 838():23-31. PubMed ID: 30194942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
